2C-C: Difference between revisions
>White m Text replacement - "{| |- | 17px''Main articles: Research chemicals § Toxicity and harm potential'' ''&'' ''Responsible use § Hallucinogens'' |}" to "{{further|Research chemicals#Toxicity and harm potential|Responsible use #Hallucinogens}}" |
>Benzofury m Including Brazil on legal section. |
||
Line 92: | Line 92: | ||
==Legal issues== | ==Legal issues== | ||
*'''Brazil:''' Possession, production and sale is illegal. | |||
*'''United States:''' 2C-C is listed in Schedule I of section 202(c) of the Controlled Substances Act in the United States. This was signed into law as of July 2012 under the Food and Drug Administration Safety and Innovation Act.<ref>S. 3187: Food and Drug Administration Safety and Innovation Act, Subtitle D-Synthetic Drugs | http://www.govtrack.us/congress/bills/112/s3187/text</ref> | *'''United States:''' 2C-C is listed in Schedule I of section 202(c) of the Controlled Substances Act in the United States. This was signed into law as of July 2012 under the Food and Drug Administration Safety and Innovation Act.<ref>S. 3187: Food and Drug Administration Safety and Innovation Act, Subtitle D-Synthetic Drugs | http://www.govtrack.us/congress/bills/112/s3187/text</ref> | ||
*'''United Kingdom:''' 2C-C is a Class A controlled substance as it is covered by the phenethylamine derivatives clause of the Misuse of Drugs Act of 1971. | *'''United Kingdom:''' 2C-C is a Class A controlled substance as it is covered by the phenethylamine derivatives clause of the Misuse of Drugs Act of 1971. |